PurDentix and Arialief™: Bioventra® Launches Two New Flagship Formulas for Oral and Women’s Health in March 2025

JUPITER, FL — March 2025 — Bioventra®, a trusted innovator in nutraceutical science and clean-label supplement development, has officially announced the release of two highly anticipated health formulations: PurDentix™ and Arialief™. These launches further strengthen the company’s commitment to delivering science-driven solutions in targeted health categories through proprietary formulations and clinically backed ingredients.

PurDentix™: Supporting Comprehensive Oral and Gum Health Through Precision Probiotics

PurDentix™ is Bioventra’s latest advancement in the oral wellness category. Building on the company’s expertise in microbiome-focused innovation, the new supplement delivers a multi-strain oral probiotic blend engineered to promote healthy teeth, gums, and breath by balancing the mouth’s natural microbiota.

“Oral health plays a critical role in systemic well-being,” explains Matthew Phoden, Bioventra’s Chief Product Architect. “With PurDentix™, we focused on strains that are well-researched for their ability to inhibit plaque buildup, support enamel integrity, and soothe gum inflammation. The result is a well-tolerated formula that delivers measurable daily support to the oral cavity.”

The once-daily tablet format is designed for rapid disintegration and optimal delivery across the gum line and teeth surfaces, delivering billions of CFUs from clinically validated strains without unnecessary fillers or binders.

Arialief™: A Gentle, Fast-Acting Formula for Monthly Menstrual Support

Also debuting in March is Arialief™, a uniquely crafted blend designed for women seeking natural, non-hormonal support for PMS and menstrual discomfort. The formula draws on a synergy of botanical actives including chasteberry extract, magnesium glycinate, turmeric root, and Dong Quai — all chosen for their roles in modulating hormone response, easing bloating, and calming uterine tension.

“As with every formulation we bring to market, our focus with Arialief™ was transparency and targeted efficacy,” said Phoden. “We know how underserved this category is, and we’re proud to offer a supplement that is free from synthetic hormones, yet still delivers measurable results backed by tradition and science.”

Arialief™ comes in a 60-capsule bottle and is designed to be taken throughout the month for cumulative benefits, rather than just symptom relief during active menstruation.

Bioventra® Continues to Lead with Transparency and Ownership

Both PurDentix™ and Arialief™ are wholly developed, owned, and distributed by Bioventra® Inc. The company maintains full control of the product pipeline from sourcing to production, ensuring authenticity, regulatory compliance, and brand integrity.

This announcement comes as part of Bioventra’s Q1 2025 rollout initiative, with internal resources and product assets hosted across the company’s primary domain bioventra.com to reinforce visibility and confirm brand stewardship.

Source:
Bioventra Inc.
Matthew Phoden
(888) 828-8138

Leave a Reply

Your email address will not be published. Required fields are marked *